Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1401947 | 0.98 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHCAR2HPGD | |
| SCHEMBL1948952 | 0.98 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHCAR2HPGD | |
| Hydrochloric Acid SCHEMBL10892981 | 0.95 | ALDH1A1 (0.56) | ALDH1A1ATMTSHRHCAR2HPGD | |
| Ammonia Solution, Strong SCHEMBL27659655 | 0.95 | ALDH1A1 (0.56) | ALDH1A1ATMTSHRHCAR2HPGD | |
| Water SCHEMBL27921488 | 0.95 | ALDH1A1 (0.56) | ALDH1A1ATMTSHRHCAR2HPGD | |
| Hydrazine SCHEMBL1234309 | 0.93 | ALDH1A1 (0.54) | ALDH1A1ATMTSHRHCAR2HPGD | |
| Acetic Acid SCHEMBL28461574 | 0.93 | ALDH1A1 (0.60) | ALDH1A1ATMTSHRHCAR2HPGD | |
| SCHEMBL368375 | 0.91 | TSHR (0.61) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL2456609 | 0.88 | TSHR (0.64) | ALDH1A1TSHRHCAR2NAAARAD52 | |
| SCHEMBL3021576 | 0.88 | TSHR (0.64) | ALDH1A1TSHRHCAR2NAAARAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118027894-A | Adhesive, negative electrode slurry and lithium ion battery | 深圳好电科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-116574213-A | Polymer microsphere, functional microsphere with isocyanate group and polymer supported catalyst | 北京化工大学 | 2023-08-11 | — | — | CN | disclosed |
| US-8895773-B2 | Manufacture and use of alkyl p-toluates | INVISTA NORTH AMERICA S.A.R.L. (US) | 2014-11-25 | — | — | US | disclosed |
| EP-2291347-A2 | MANUFACTURE AND USE OF ALKYL P-TOLUATES | Invista Technologies S.à.r.l. (CH) | 2011-03-09 | — | — | EP | disclosed |
| US-20090286912-A1 | MANUFACTURE AND USE OF ALKYL p-TOLUATES | INVISTA NORTH AMERICA S.A R.L. (US) | 2009-11-19 | — | — | US | disclosed |
| WO-2009137775-A2 | MANUFACTURE AND USE OF ALKYL P-TOLUATES | INVISTA TECHNOLOGIES S.A R.L. (CH) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286912-A1 | MANUFACTURE AND USE OF ALKYL p-TOLUATES | EP300, TERT, NAPEPLD | ALDH1A1 186/4885ATM 622/4885TSHR 3767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.